Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 6
1966 14
1967 8
1968 14
1969 7
1970 10
1971 13
1972 10
1973 12
1974 19
1975 17
1976 21
1977 28
1978 27
1979 46
1980 34
1981 48
1982 56
1983 71
1984 70
1985 80
1986 84
1987 86
1988 65
1989 94
1990 77
1991 83
1992 71
1993 70
1994 65
1995 62
1996 57
1997 53
1998 68
1999 55
2000 46
2001 48
2002 45
2003 56
2004 52
2005 44
2006 50
2007 60
2008 64
2009 78
2010 70
2011 80
2012 83
2013 67
2014 64
2015 52
2016 32
2017 45
2018 31
2019 22
2020 7
2021 14
2022 12
2023 14
2024 13
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,646 results

Results by year

Filters applied: . Clear all
Page 1
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
Dhayat NA, Bonny O, Roth B, Christe A, Ritter A, Mohebbi N, Faller N, Pellegrini L, Bedino G, Venzin RM, Grosse P, Hüsler C, Koneth I, Bucher C, Del Giorno R, Gabutti L, Mayr M, Odermatt U, Buchkremer F, Ernandez T, Stoermann-Chopard C, Teta D, Vogt B, Roumet M, Tamò L, Cereghetti GM, Trelle S, Fuster DG. Dhayat NA, et al. N Engl J Med. 2023 Mar 2;388(9):781-791. doi: 10.1056/NEJMoa2209275. N Engl J Med. 2023. PMID: 36856614 Free article. Clinical Trial.
There was no relation between the hydrochlorothiazide dose and the occurrence of a primary end-point event (P = 0.66). Hypokalemia, gout, new-onset diabetes mellitus, skin allergy, and a plasma creatinine level exceeding 150% of the baseline level were more common among pa …
There was no relation between the hydrochlorothiazide dose and the occurrence of a primary end-point event (P = 0.66). Hypokalemia, g …
Oral combined hydrochlorothiazide and lisinopril vs nifedipine for postpartum hypertension: a comparative-effectiveness pilot randomized controlled trial.
Fishel Bartal M, Blackwell SC, Pedroza C, Lawal D, Amro F, Samuel J, Chauhan SP, Sibai BM. Fishel Bartal M, et al. Am J Obstet Gynecol. 2023 May;228(5):571.e1-571.e10. doi: 10.1016/j.ajog.2023.01.015. Epub 2023 Feb 12. Am J Obstet Gynecol. 2023. PMID: 36787814 Clinical Trial.
Participants were randomized to receive either combined hydrochlorothiazide and lisinopril therapy or nifedipine therapy after stratifying the participants by diagnosis (chronic hypertension vs hypertensive disorders of pregnancy). ...CONCLUSION: The results of the pilot t …
Participants were randomized to receive either combined hydrochlorothiazide and lisinopril therapy or nifedipine therapy after strati …
Clinical trial of a new diuretic, furosemide: comparison with hydrochlorothiazide and mercaptomerin.
Godwin TF, Gunton RW. Godwin TF, et al. Can Med Assoc J. 1965 Dec 18;93(25):1296-300. Can Med Assoc J. 1965. PMID: 5320846 Free PMC article. Clinical Trial.
A clinical trial was carried out with the object of comparing the effects of furosemide, a new oral diuretic agent, with those of mercaptomerin and hydrochlorothiazide. Eleven edematous patients were chosen for the study and the diuretics were rotated, each drug being prec …
A clinical trial was carried out with the object of comparing the effects of furosemide, a new oral diuretic agent, with those of mercaptome …
Telmisartan and hydrochlorothiazide antihypertensive treatment in high sodium intake population: a randomized double-blind trial.
Zhang P, Wang H, Sun L, Zhang J, Xi Y, Wu Y, Yan LL, Li X, Sun N. Zhang P, et al. J Hypertens. 2017 Oct;35(10):2077-2085. doi: 10.1097/HJH.0000000000001407. J Hypertens. 2017. PMID: 28509725 Clinical Trial.
OBJECTIVES: To compare the blood pressure (BP)-lowering effects of telmisartan 40 mg/day and hydrochlorothiazide (HCTZ) 25 mg/day in high sodium intake patients with mild-to-moderate hypertension in China. ...Further studies are needed to evaluate the plausible superiority …
OBJECTIVES: To compare the blood pressure (BP)-lowering effects of telmisartan 40 mg/day and hydrochlorothiazide (HCTZ) 25 mg/day in …
The efficacy and safety of valsartan and combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension - the VICTORY trial.
Accetto R, Chazova IY, Sirenko Y, Vincelj J, Widimsky J Jr, Barbič-Žagar B. Accetto R, et al. Kardiol Pol. 2017;75(1):55-64. doi: 10.5603/KP.a2016.0135. Epub 2016 Oct 7. Kardiol Pol. 2017. PMID: 27714718 Free article. Clinical Trial.
BACKGROUND AND AIM: The aim of the trial was to establish the efficacy and safety of Valsacor (valsartan) and Valsacombi (combination of valsartan and hydrochlorothiazide) in a wide variety of patient populations with mild to moderate arterial hypertension. ...The initial …
BACKGROUND AND AIM: The aim of the trial was to establish the efficacy and safety of Valsacor (valsartan) and Valsacombi (combination of val …
Clinical efficacy and ultrasound inspection of the treatment of hypertensive heart patients with Valsartan combined with hydrochlorothiazide.
Qian D, Tao H, Dai M, Zhang C. Qian D, et al. Pak J Pharm Sci. 2018 Jul;31(4(Special)):1659-1662. Pak J Pharm Sci. 2018. PMID: 30203756 Clinical Trial.
Where, the reference group was solely treated with valsartan, while the study group received hydrochlorothiazide treatment on this basis. The therapeutic effects of the two groups were observed and analyzed. ...The combination of Valsartan and hydrochlorothiazide fo …
Where, the reference group was solely treated with valsartan, while the study group received hydrochlorothiazide treatment on this ba …
Slow-release furosemide and hydrochlorothiazide in congestive cardiac failure: a controlled trial.
Vermeulen A, Chadha DR. Vermeulen A, et al. J Clin Pharmacol. 1982 Nov-Dec;22(11-12):513-9. doi: 10.1002/j.1552-4604.1982.tb02644.x. J Clin Pharmacol. 1982. PMID: 6761370 Clinical Trial.
Thirty-eight ambulatory patients with congestive cardiac failure took part in a double-blind clinical trial of 50 mg hydrochlorothiazide orally daily and slow-release formulation of 60 mg furosemide orally daily. ...Both treatments were clinically well tolerated; however, …
Thirty-eight ambulatory patients with congestive cardiac failure took part in a double-blind clinical trial of 50 mg hydrochlorothiazide …
An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy.
Burris JF, Weir MR, Oparil S, Weber M, Cady WJ, Stewart WH. Burris JF, et al. JAMA. 1990 Mar 16;263(11):1507-12. JAMA. 1990. PMID: 2407872 Clinical Trial.
This multicenter, factorial-design trial assessed the safety and additive antihypertensive efficacy of a slow-release (SR) formulation of diltiazem hydrochloride given alone or in combination with hydrochlorothiazide for treatment of mild to moderate hypertension. After a …
This multicenter, factorial-design trial assessed the safety and additive antihypertensive efficacy of a slow-release (SR) formulation of di …
Effects of Triamterene in Hospitalized Patients with Heart Failure and Diuretic Resistance: A Randomized Clinical Trial.
Taban-Sadeghi M, Khani E, Khezripour K, Enamzadeh E, Safaei N, Entezari-Maleki T. Taban-Sadeghi M, et al. J Clin Pharmacol. 2023 Dec;63(12):1352-1358. doi: 10.1002/jcph.2321. Epub 2023 Aug 10. J Clin Pharmacol. 2023. PMID: 37493211 Clinical Trial.
Patients were randomized to receive either triamterene 50 mg plus hydrochlorothiazide 25 mg (n = 23) or hydrochlorothiazide 50 mg alone (n = 22) until hospital discharge. ...
Patients were randomized to receive either triamterene 50 mg plus hydrochlorothiazide 25 mg (n = 23) or hydrochlorothiazide 50 …
A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide.
Frishman WH, Bryzinski BS, Coulson LR, DeQuattro VL, Vlachakis ND, Mroczek WJ, Dukart G, Goldberg JD, Alemayehu D, Koury K. Frishman WH, et al. Arch Intern Med. 1994 Jul 11;154(13):1461-8. Arch Intern Med. 1994. PMID: 8018001 Clinical Trial.
The addition of hydrochlorothiazide (or bisoprolol) to therapy with bisoprolol (or hydrochlorothiazide) produced an incremental reduction in blood pressure. Dosages of hydrochlorothiazide as low as 6.25 mg/d contributed a significant antihypertensive effect. …
The addition of hydrochlorothiazide (or bisoprolol) to therapy with bisoprolol (or hydrochlorothiazide) produced an incrementa …
2,646 results